BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 4452282)

  • 1. Sequential chromosome analysis of Walker carcinosarcoma-256 implanted into rats after frozen storage.
    Kajino G; Murase T; Amo H
    Cryobiology; 1974 Dec; 11(6):500-7. PubMed ID: 4452282
    [No Abstract]   [Full Text] [Related]  

  • 2. Chromosomal analysis of Walker carcinosarcoma-256: karyological differences in two sublines and their original line.
    Kajino G; Murase T; Terashima Y; Amo H
    Gan; 1973 Dec; 64(6):629-32. PubMed ID: 4779859
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cytogenetic characteristics of Walker carcinosarcoma and its metastases].
    Kiricuta I; Olinici CD
    Vopr Onkol; 1972; 18(3):60-3. PubMed ID: 5017839
    [No Abstract]   [Full Text] [Related]  

  • 4. [On defined tumor-tolerant and tumor-resistant strains of CFN rats. (Genetic and immunobiological problems in the transplantation of Walker-256 carcinosarcoma in various homologous hosts)].
    Lehmann FE; Meyer V
    Arch Julius Klaus Stift Vererbungsforsch Sozialanthropol Rassenhyg; 1963; 38(3-4):242-52. PubMed ID: 5899906
    [No Abstract]   [Full Text] [Related]  

  • 5. [Heterotransplantation of Zajdela hepatoma of the rat to golden hamsters, mice, and Chinese hamsters].
    Wieser O
    Verh Dtsch Ges Pathol; 1968; 52():421-5. PubMed ID: 4182272
    [No Abstract]   [Full Text] [Related]  

  • 6. A study of chromosomal behaviour in primary tumour cells and lymphatic metastases under the action of the cytostatic IOB 82.
    Andreescu M; Dobre V; Maltezeanu G; Mateescu C
    Neoplasma; 1970; 17(5):475-83. PubMed ID: 5486298
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chromosome studies on in vivo and in vitro grown Walker carcinoma 256].
    Wieser O; Kinzel V; Mohr U
    Z Krebsforsch; 1968; 71(2):124-8. PubMed ID: 4233459
    [No Abstract]   [Full Text] [Related]  

  • 8. C-banding of two Walker 256 rat carcinoma cell lines sensitive and resistant to bifunctional mustards.
    Hartley-Asp B; Billström A; Tew KD
    Anticancer Res; 1987; 7(2):209-13. PubMed ID: 3592633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Carcinemia and metastasis of Walker carcinosarcoma implanted in the wall of the stomach].
    Sukovatykh LS; Fisher ME; Makkavaeva MIu; Fradkin SZ; Mashevskiĭ AA
    Vopr Onkol; 1970; 16(6):60-3. PubMed ID: 5501581
    [No Abstract]   [Full Text] [Related]  

  • 10. Inducing tumor immunity by specific tumor antigens.
    Schwind JV
    Oncology; 1975; 32(5-6):324-6. PubMed ID: 1228544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pattern of proteasome expression in Walker 256 tumor cells after their transplantation into the Brattleboro rats with genetic defect of vasopressin synthesis.
    Sharova NP; Melnikova VI; Khegai II; Karpovaa YD; Dmitrieva SB; Astakhova TM; Afanas'eva MA; Popova NA; Ivanova LN; Zakharova LA
    Dokl Biochem Biophys; 2008; 419():93-7. PubMed ID: 18505166
    [No Abstract]   [Full Text] [Related]  

  • 12. Walker 256 tumor growth in rats with hereditary defect of vasopressin synthesis.
    Khegai II; Popova NA; Zakharova LA; Ivanova LN
    Bull Exp Biol Med; 2006 Sep; 142(3):344-6. PubMed ID: 17426845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug resistance study in a mixed nitrogen mustard-sensitive-resistant tumour.
    Ujházy V
    Neoplasma; 1969; 16(4):467-8. PubMed ID: 5344233
    [No Abstract]   [Full Text] [Related]  

  • 14. Walker rat carcinoma cells are exceptionally sensitive to cis-diamminedichloroplatinum(II) (cisplatin) and other difunctional agents but not defective in the removal of platinum-DNA adducts.
    Rawlings CJ; Roberts JJ
    Mutat Res; 1986 Sep; 166(2):157-68. PubMed ID: 3762562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy of solid Walker carcinosarcoma 256 with bleomycin after synchronization with hydroxyurea.
    Volm M; Mattern J; Weber N; Wayss K
    Cancer Chemother Pharmacol; 1980; 4(2):89-93. PubMed ID: 6156026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regression of Walker 256 carcinosarcoma in vasopressin-deficient Brattleboro rats is accompanied by a changed laminin pattern.
    Khegay II; Ivanova LN
    Biochem Genet; 2015 Apr; 53(1-3):1-7. PubMed ID: 25854851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor and genotoxic effects of lactoferrin in Walker-256 tumor-bearing rats.
    Chekhun VF; Storchai DM; Todor IN; Borikun TV; Lukianova NY
    Exp Oncol; 2018 Oct; 40(3):200-204. PubMed ID: 30284996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Characteristics of the growth and metastasis of Walker carcinosarcoma following continuous intramuscular passage].
    Shchitkov KF; Bolonina NI; Mandrik EV; Krasner NE
    Vopr Onkol; 1973; 19(3):96-7. PubMed ID: 4762702
    [No Abstract]   [Full Text] [Related]  

  • 19. A simple method to establish simulated gastric and intestinal cancer in rats by mucosal implantation of Walker tumour.
    Broyn T
    Acta Chir Scand; 1974; 140(6):481-5. PubMed ID: 4428926
    [No Abstract]   [Full Text] [Related]  

  • 20. [Lactate dehydrogenase isoenzymatic spectrum in rats with Walker carcinosarcoma].
    Zel'vin BM; Bolonina NI; Tereshchenko IP
    Vopr Onkol; 1974; 20(4):76-9. PubMed ID: 4439819
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.